Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
home: iStockAnalyst.com Feed
July 10, 2012 at 13:22 PM EDT
Synta (SNTA)- The Signal Looks Real
So what does the market really think about Synta’s (SNTA) lung cancer data? 2 weeks ago, the stock lost 33% in 1 trading session following interim results from the phase II trial for the company’s lead agent, ganetespib. [More...]
Read More >>
Array Biopharma, Inc.
Onyx Pharmaceuticals, Inc.
Synta Pharmaceuticals, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Bots go here